160 Health International Limited Issues First-Ever Positive Profit Alert for FY2025

Key Highlights

• Return to Profitability: 160 Health International Limited (“the Company”) expects to report an adjusted net profit (non-IFRS measure) in the range of RMB 3.0 million to RMB 5.0 million for the financial year ended December 31, 2025. This compares to a significant adjusted net loss of RMB 31.5 million reported for the year ended December 31, 2024.
• First Full-Year Adjusted Net Profit: This marks the first time the Company and its subsidiaries (“the Group”) have achieved a full-year profit in terms of adjusted net profit (non-IFRS measure) since listing.
• Key Drivers:
  • Year-on-year revenue growth, which contributed to an increase in gross profit.
  • Refined management and ongoing enhancements in operational efficiency, resulting in a significant reduction in total operating expenses including selling and marketing, research and development, and administrative costs.
• Definition of Adjusted Net Profit: The Company defines “adjusted net profit” as profit for the year after adding back share-based compensation expenses and listing expenses. These are non-cash and non-operational items, which the Board believes provides a clearer picture of the Group’s operational performance.
• Preliminary Results: The figures are based on unaudited consolidated management accounts and remain subject to finalization, audit, and review. The final results may differ from the current estimates.

Implications for Shareholders and Investors

• Price-Sensitive Information: The turnaround from a substantial loss to a profit is a significant milestone for the Company. This positive profit alert represents a material improvement in the Company’s financial health and could influence investor sentiment and potentially move the share price.
• Caution Advised: Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares, as the information provided is preliminary, unaudited, and subject to adjustment.
• Upcoming Disclosure: More detailed and audited financial results will be published in the Company’s annual results announcement for 2025, expected by the end of March 2026.

Board and Leadership

The announcement is authorized by Mr. Luo Ningzheng, Chairman of the Board, Executive Director, and Chief Executive Officer. The Board comprises a mix of executive, non-executive, and independent non-executive directors, ensuring a broad oversight of the Company’s governance.

Conclusion

This positive profit alert is the first of its kind for 160 Health International and reflects a step-change in the Company’s financial performance. The reduction in operating expenses and growth in revenue are key catalysts for this turnaround. Investors should monitor the upcoming audited results announcement for confirmation and further insights.

Disclaimer: The information provided above is based on the Company’s unaudited management accounts and is subject to change following audit and further review. Investors are urged to exercise caution and not to rely solely on this announcement for their investment decisions. The Company and its Board accept no responsibility for any losses arising from reliance on this information.

View 160 HEALTH Historical chart here